HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuru Futakuchi Selected Research

1-O-hexyl-2,3,5-trimethylhydroquinone

12/2002Effects of antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone or ascorbic acid on carcinogenesis induced by administration of aminopyrine and sodium nitrite in a rat multi-organ carcinogenesis model.
2/2002Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuru Futakuchi Research Topics

Disease

35Neoplasms (Cancer)
01/2022 - 02/2002
17Neoplasm Metastasis (Metastasis)
02/2020 - 10/2002
15Carcinogenesis
11/2017 - 02/2002
7Breast Neoplasms (Breast Cancer)
02/2020 - 07/2008
7Osteolysis
02/2020 - 02/2008
7Prostatic Neoplasms (Prostate Cancer)
01/2018 - 09/2005
4Mesothelioma
07/2014 - 01/2009
4Adenocarcinoma
05/2010 - 02/2002
4Hepatocellular Carcinoma (Hepatoma)
01/2005 - 05/2002
3Hyperthermia
05/2008 - 09/2005
3Body Weight (Weight, Body)
01/2004 - 10/2002
2Lymphoma (Lymphomas)
01/2022 - 11/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2019 - 01/2014
2Fibrosis (Cirrhosis)
10/2018 - 01/2014
2Inflammation (Inflammations)
10/2018 - 07/2014
2Malignant Mesothelioma
07/2016 - 07/2015
2Hyperplasia
01/2014 - 05/2010
2Aberrant Crypt Foci
08/2008 - 04/2002
2Bone Resorption
02/2008 - 01/2006
1Rheumatoid Arthritis
04/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2022
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1B-Cell Leukemia (Leukemia, B Cell)
01/2022
1Pancreatic Ductal Carcinoma
07/2019
1Renal Cell Carcinoma (Grawitz Tumor)
11/2017
1Reperfusion Injury
01/2016
1Asbestosis
07/2015
1Hydrothorax
07/2015
1Lung Neoplasms (Lung Cancer)
07/2015
1Virus Diseases (Viral Diseases)
05/2015
1Intestinal Polyps
10/2014
1Polyps
10/2014
1Pleural Diseases
07/2014

Drug/Important Bio-Agent (IBA)

6Carbon Nanotubes (Carbon Nanotube)IBA
10/2018 - 01/2009
6LigandsIBA
03/2018 - 05/2002
5Diethylnitrosamine (N-Nitrosodiethylamine)IBA
08/2007 - 05/2002
4AsbestosIBA
07/2016 - 12/2012
4titanium dioxide (Titania)FDA Link
01/2012 - 01/2009
4Transforming Growth Factor beta (TGF-beta)IBA
05/2010 - 02/2008
4N-nitrosomorpholineIBA
08/2007 - 10/2002
3LactoferrinIBA
10/2014 - 01/2009
3CarcinogensIBA
05/2010 - 10/2002
3Antisense OligonucleotidesIBA
05/2010 - 02/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2010 - 01/2004
3Liposomes (Liposome)IBA
05/2008 - 09/2005
31,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
07/2003 - 02/2002
3Dimenhydrinate (DMH)FDA LinkGeneric
07/2003 - 02/2002
2Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2013
2Phosphotransferases (Kinase)IBA
10/2019 - 01/2009
2Transforming Growth Factors (Transforming Growth Factor)IBA
10/2019 - 02/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2016 - 02/2008
2Cre recombinaseIBA
05/2015 - 02/2010
2diisopropanolnitrosamineIBA
01/2014 - 05/2010
2Proliferating Cell Nuclear Antigen (PCNA)IBA
07/2013 - 04/2002
2Matrix Metalloproteinases (MMPs)IBA
05/2010 - 07/2008
2Cathepsin GIBA
02/2010 - 07/2008
2RANK LigandIBA
01/2009 - 07/2008
2Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
01/2009 - 01/2009
2Cathepsin KIBA
07/2008 - 05/2005
2Ferrosoferric Oxide (Magnetite)FDA Link
05/2006 - 09/2005
2Messenger RNA (mRNA)IBA
01/2004 - 05/2002
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2004 - 10/2002
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2004 - 10/2002
2Safflower OilFDA Link
07/2003 - 04/2002
2Conjugated Linoleic AcidsIBA
07/2003 - 04/2002
2Fatty Acids (Saturated Fatty Acids)IBA
07/2003 - 04/2002
21-O-hexyl-2,3,5-trimethylhydroquinoneIBA
12/2002 - 02/2002
2AntioxidantsIBA
12/2002 - 02/2002
22- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
04/2002 - 02/2002
2benzocycloheptapyridineIBA
04/2002 - 02/2002
1Methotrexate (Mexate)FDA LinkGeneric
04/2022
1Protein Isoforms (Isoforms)IBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Phenobarbital (Luminal)FDA Link
02/2020
1Biomarkers (Surrogate Marker)IBA
07/2019
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
04/2019
1Crocidolite Asbestos (Blue Asbestos)IBA
10/2018
1Interleukin-18 (Interleukin 18)IBA
10/2018
1Interleukin-2 (IL2)IBA
10/2018
1OsteoprotegerinIBA
03/2018
1MicroRNAs (MicroRNA)IBA
01/2018
1human MIRN940 microRNAIBA
01/2018
1ferric nitrilotriacetateIBA
11/2017
1Monoclonal AntibodiesIBA
11/2017
1adenovirus receptorIBA
11/2017
1Protein Sorting Signals (Signal Peptide)IBA
11/2017
1Complement System Proteins (Complement)IBA
11/2017
1IronIBA
11/2017
14-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
01/2017
1CytokinesIBA
04/2016
1AnaphylatoxinsIBA
01/2016
1Peptides (Polypeptides)IBA
01/2016
1Chemokine CCL3IBA
07/2015
1Antiviral Agents (Antivirals)IBA
05/2015
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2015

Therapy/Procedure

8Therapeutics
03/2018 - 09/2005
2Subcutaneous Injections
07/2003 - 12/2002
1Immunotherapy
11/2017
1Laparotomy
05/2015